276 related articles for article (PubMed ID: 17349901)
1. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.
Baroletti S; Hurwitz S; Conti NA; Fanikos J; Piazza G; Goldhaber SZ
Am J Med; 2012 Jan; 125(1):44-9. PubMed ID: 22075045
[TBL] [Abstract][Full Text] [Related]
6. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
7. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
8. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
9. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
Matsuo T; Tomaru T; Kario K; Hirokawa T;
Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
Mattioli AV; Bonetti L; Sternieri S; Mattioli G
Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
[TBL] [Abstract][Full Text] [Related]
11. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia.
Warkentin TE; Makris M; Jay RM; Kelton JG
Am J Med; 2008 Jul; 121(7):632-6. PubMed ID: 18589060
[TBL] [Abstract][Full Text] [Related]
12. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopaenia.
Gounden R; Blockman M
Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
[TBL] [Abstract][Full Text] [Related]
15. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support.
Schenk S; El-Banayosy A; Prohaska W; Arusoglu L; Morshuis M; Koester-Eiserfunke W; Kizner L; Murray E; Eichler P; Koerfer R; Greinacher A
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1373-81.e4. PubMed ID: 16733172
[TBL] [Abstract][Full Text] [Related]
17. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.
Shelat SG; Tomaski A; Pollak ES
Clin Appl Thromb Hemost; 2008 Oct; 14(4):410-4. PubMed ID: 17895512
[TBL] [Abstract][Full Text] [Related]
18. Emergency department awareness of heparin-induced thrombocytopenia: how frequently is risk assessment documented in patients with thrombosis?
Levine RL; Funk R; Hergenroeder GW; Hursting MJ
Am J Med Qual; 2010; 25(5):365-9. PubMed ID: 20522721
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia: diagnosis and management.
Hassell K
Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
[TBL] [Abstract][Full Text] [Related]
20. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]